logo
Select company
Select metric
-10662.82%EBITDA Margin
VS
Market
2
Sector
5
Industry
2
History
18
$ 8.6Close
$ 6.39 - $ 2.7K 52-Week Range
Ticker Information

Ticker

ACON

Company Name

ACLARION INC

Sector

Healthcare

Industry

Health Information Services

Exchange

NASDAQ

ACLARION INC - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ACON - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -6.71M-10662.82%$ 62.95K
3/31/2025$ -6.23M-11407.15%$ 54.6K
12/31/2024$ -6.26M-13700.28%$ 45.72K
9/30/2024$ -5.16M-10463.57%$ 49.29K
6/30/2024$ -4.7M-8718.5%$ 53.95K
3/31/2024$ -5.02M-8353.1%$ 60.05K
12/31/2023$ -4.14M-5490.98%$ 75.4K
9/30/2023$ -4.1M-4871.69%$ 84.13K
6/30/2023$ -4.89M-5873.42%$ 83.28K
3/31/2023$ -5.83M-7587.91%$ 76.89K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ACLARION INC's latest trailing twelve months (TTM) EBITDA % stands at -7108.75%.
  • Over the past 5 years, ACLARION INC's average EBITDA % has been -8667.21%.
  • The median EBITDA % for ACLARION INC during this period was -8535.8%
  • ACLARION INC reached its highest EBITDA % over the past 5 years at -4871.69%.
  • The lowest EBITDA % recorded by ACLARION INC in the same timeframe -13700.28%

ACLARION INC's EBITDA % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA % Benchmarks
CompanyEBITDA %
SILO : SILO PHARMA INC -6765.89%SLRX : SALARIUS PHARMACEUTICALS INC -BBLG : BONE BIOLOGICS CORP -TOVX : THERIVA BIOLOGICS INC -REVB : REVELATION BIOSCIENCES INC -ADTX : ADITXT INC -247080.61%DRMA : DERMATA THERAPEUTICS INC -GLTO : GALECTO INC -SHPH : SHUTTLE PHARMACEUTICALS HOLDINGS INC -AZTR : AZITRA INC -

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for ACLARION INC is calculated as follows: EBITDA [ $ -4.29M ] / Revenues [ $ 60.29K ]
(=) EBITDA % [ -7108.75% ]

ACON - EBITDA Margin, Last 5 years

-13700.28%

Minimum

Dec 31, 2024

-4871.69%

Maximum

Sep 30, 2023

-8667.21%

Average

-8535.8%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-74.33%
max97.24%
average16.2%
median14.74%
std26.73%